Renal Denervation procedure across its health system, targeting patients with uncontrolled high blood pressure--a therapy shown in clinical trials to reduce major cardiovascular events by 20%, stroke ...

At the 43rd annual J.P. Morgan Healthcare Conference on Monday, Medtronic CEO Geoff Martha mixed in some breaking news with his usual pitch to investors. Just hours earlier, the Centers for Medicare ...

(Reuters) - The U.S. Food and Drug Administration on Friday approved the use of Medtronic's treatment device in a surgery called renal denervation in patients whose high blood pressure cannot be ...

For some, the COVID-19 pandemic might feel far removed from their current day-to-day lives. But others still grapple with long-term health ramifications. After battling COVID-19, Jimmy Strohmaier was ...

The US Food and Drug Administration has approved the ultrasound-based Paradise renal denervation system for the treatment of hypertension, marking the culmination of more than a decade of work—with ...

Denervation by catheter ablation, having broached the drug-intensive world of hypertension with some success, is venturing into a clinical realm that has repeatedly crushed attempts at medical therapy ...

It’s been over a year since renal denervation systems for the treatment of hypertension became available to US physicians, but uptake has been spotty as centers try to figure out how to cover the ...

Please provide your email address to receive an email when new articles are posted on . After many years and multiple trials, two FDA-approved renal denervation systems are now available in the U.S.

Medtronic asserted that key markets it targets including PFA and renal denervation represent lucrative opportunities in the ...